Your Article Summary
See Latest ArticlesE-selectin, interleukin 18, serum amyloid A, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapy
Journal of Rheumatology, 07/02/09
Visvanathan S et al. – Study demonstrates that treatment with golimumab (human monoclonal antibody to TNF-α) + methotrexate (MTX) therapy in patients with active rheumatoid arthritis (RA) significantly decreased several inflammatory biomarkers. Decreases in serum levels of serum amyloid A (SAA), E-selectin, and MMP-9 at wk 4 may be useful in predicting clinical response at wk 16.
Methods- Main objectives of this study were to:
- Assess the effect of golimumab + MTX on selected inflammatory biomarkers and
- Determine if these effects predict clinical response in RA
- Sera from adults with active RA despite MTX therapy, who received:
- Subcutaneous injections of placebo + MTX (n=34) or
- Golimumab 50 or 100 mg every 2 or 4 wks + MTX (n=137)
- were analyzed for levels of CRP, SAA, IL-18, E-selectin, MMP-9 and TIMP-1
- Golimumab + MTX treatment decreased serum CRP, SAA, IL-18, E-selectin, TIMP-1, and MMP-9 levels vs MTX
- This difference was noted first at wk 4; decreases were sustained through wk 16
- Larger magnitudes of decrease in all biomarkers were observed for clinical responders vs nonresponders
- Reductions in levels of SAA, E-selectin, MMP-9 at wk 4 correlated with improvement in swollen joint count (SJC) at wk 16
- Same was true for reductions in E-selectin with improvement in tender joint count at wk 16
- After accounting for the biomarkers, however, treatment group was no longer significant for SJC
Related Articles
Comparison of neurocognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatment of childhood acute lymphoblastic leukemia
Journal of Clinical Oncology, 11/09/09
Relevance Score: 71%
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: A randomised phase 2 trial
The Lancet, 11/05/09
Relevance Score: 69%
Effect of allopurinol versus urate oxidase on methotrexate pharmacokinetics in children with newly diagnosed acute lymphoblastic leukemia
Cancer, 10/26/09
Relevance Score: 68%
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor [alpha] therapies: Does the risk change with the time since start of treatment?
Arthritis & Rheumatism, 11/05/09
Relevance Score: 67%
Clinical potency of methotrexate, aminopterin, talotrexin and pemetrexed in childhood leukemias
Cancer Chemotherapy and Pharmacology, 10/05/09
Relevance Score: 66%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis
Rheumatology, 12/20/09
The 'RASor's' edge: Ras proteins and matrix destruction in arthritis
Arthritis Research & Therapy, 12/19/09
Unresponsiveness to colchicine therapy in patients with familial Mediterranean fever homozygous for the M694V mutation
Journal of Rheumatology, 12/17/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Malignancy-associated multicentric reticulohistiocytosis
Rheumatology International, 12/20/09
Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil
Rheumatology, 12/18/09
Nicotine-patch therapy on mucocutaneous lesions of Behcet's disease: A case series
Rheumatology, 12/18/09
Today in Rheumatoid Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study
Arthritis Research & Therapy, 12/19/09
Update on the genetic risk factors for rheumatoid arthritis
Expert Review of Clinical Immunology, 12/18/09
The diagnostic utilities of anti-agalactosyl IgG antibodies, anti-cyclic citrullinated peptide antibodies, and rheumatoid factors in rheumatoid arthritis
Rheumatology International, 12/18/09